Fasteris also acquired a MiSeq system.
Fasteris launched low cost run on the HiSeq: for CHF 380 we sell 10% of a single-reads channel of 1x50 bases.
Using this service, a whole bacterial genome re-sequencing project, including library preparation and bioinformatics costs less than CHF 1'500.
We also announced the acquisition of a MiSeq system, the little brother of the HiSeq that permits sequencing 50 bases in a few hours.
Discover regenHU's 3DDiscovery Evolution bio-printerregenHU will launch their new product @ the IDTechEX Show on 11-12 April 2018 in Berlin, Germany.
Genomic Health International SàrlR&D Services and Technology Platforms, Diagnostic Instrumentation / Analytical ServicesGenomic Health, Inc. is a world’s leading provider of genomic-based diagnostic tests that inform treatment decisions and help to ensure each patient receives appropriate treatment for early stage cancer. The company is applying its state-of-the-art scientific and commercial expertise and infrastructure to translate significant amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey, from screening and surveillance, through diagnosis and treatment selection.
The company is based in Redwood City, California with European headquarters in Geneva, Switzerland.